{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:12:57Z","timestamp":1788469977255,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mcp.2022.101793","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:36:42Z","timestamp":1643629002000},"page":"101793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA"],"prefix":"10.1016","volume":"61","author":[{"given":"G\u00e1bor","family":"M\u00e9hes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-8680","authenticated-orcid":false,"given":"Attila","family":"Mok\u00e1nszki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia Lilla","family":"Csoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcp.2022.101793_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.mcp.2022.101793_bib2","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.3390\/ijms22168661","article-title":"Current and future development in lung cancer diagnosis","volume":"22","author":"Nooreldeen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcp.2022.101793_bib3","doi-asserted-by":"crossref","first-page":"102237","DOI":"10.1016\/j.ctrv.2021.102237","article-title":"Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies","volume":"99","author":"Succony","year":"2021","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mcp.2022.101793_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcp.2022.101793_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib6","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.cca.2011.07.027","article-title":"Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations","volume":"412","author":"Pinzani","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mcp.2022.101793_bib7","first-page":"2","article-title":"Cell-free DNA analysis in cancer","author":"Fiala and Diamandis","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcp.2022.101793_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbiotec.2019.04.002","article-title":"Liquid biopsy for predictive mutational profiling of solid cancer: the pathologist's perspective","volume":"297","author":"M\u00e9hes","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.mcp.2022.101793_bib9","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1878-0261.12574","article-title":"Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions","volume":"13","author":"Villatoro","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1759-7714.13006","article-title":"Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling","volume":"10","author":"Guo","year":"2019","journal-title":"Thorac. Cancer."},{"key":"10.1016\/j.mcp.2022.101793_bib11","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.mcp.2022.101793_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2019.08.004","article-title":"Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients","volume":"136","author":"Song","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.mcp.2022.101793_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.21037\/tlcr.2019.07.05","article-title":"Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology","volume":"8","author":"Steinfort","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.mcp.2022.101793_bib14","first-page":"S33","article-title":"Physiology of the pleural space","volume":"7","author":"Charalampidis","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.mcp.2022.101793_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/pp-2016-0009","article-title":"Diverse properties of the mesothelial cells in health and disease","volume":"1","author":"Kawanishi","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.mcp.2022.101793_bib16","doi-asserted-by":"crossref","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.mcp.2022.101793_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1183\/09031936.02.00062102","article-title":"Physiology and pathophysiology of pleural fluid turnover","volume":"20","author":"Zocchi","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mcp.2022.101793_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0039-1693648","article-title":"Physiologic basis of symptoms in pleural disease","volume":"40","author":"DeBiasi","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.mcp.2022.101793_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00063198-200107000-00006","article-title":"Pleural effusion due to pulmonary emboli","volume":"7","author":"Light","year":"2001","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.mcp.2022.101793_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/crj.12982","article-title":"Pleura revisited: from histology and pathophysiology to pathology and molecular biology","volume":"13","author":"Karpathiou","year":"2019","journal-title":"Clin. Res. J."},{"key":"10.1016\/j.mcp.2022.101793_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000447687","article-title":"Malignant nonhematological effusion characterization by flow cytometry","volume":"60","author":"Davidson","year":"2016","journal-title":"Acta Cytol."},{"key":"10.1016\/j.mcp.2022.101793_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/17476348.2020.1684266","article-title":"Advances in pleural effusion diagnostics","volume":"14","author":"Ferreiro","year":"2020","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.mcp.2022.101793_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9610(99)80257-8","article-title":"Diagnosis and management of malignant pleural effusions","volume":"170","author":"Fenton","year":"1995","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.mcp.2022.101793_bib24","first-page":"1021","article-title":"Pleural involvement in lung cancer","volume":"7","author":"Agalioti","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.mcp.2022.101793_bib25","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta\u2010analysis","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mcp.2022.101793_bib26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1378\/chest.125.4.1546","article-title":"Pleural effusions in hematologic malignancies","volume":"125","author":"Alexandrakis","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.mcp.2022.101793_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2016.06.013","article-title":"FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited","volume":"142","author":"Ataseven","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/resp.12874","article-title":"Malignant pleural fluid from mesothelioma has potent biological activities","volume":"22","author":"Cheah","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.mcp.2022.101793_bib29","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","article-title":"The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review","volume":"10","author":"Al\u00ec","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.mcp.2022.101793_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: tumor-host interactions unleashed","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mcp.2022.101793_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/medicina55080490","article-title":"Malignant pleural effusion and its current management: a review","volume":"55","author":"Skok","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.mcp.2022.101793_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000113629","article-title":"Pathophysiology of the pleura","volume":"75","author":"Jantz","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.mcp.2022.101793_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5301\/JBM.2012.9261","article-title":"Interleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values","volume":"27","author":"Kotyza","year":"2012","journal-title":"A Review, Int. J. Biol. Markers."},{"key":"10.1016\/j.mcp.2022.101793_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.03.00403902","article-title":"Immunological mechanisms in pleural disease","volume":"21","author":"Antony","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mcp.2022.101793_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm_00000001","article-title":"The angiogenetic pathway in malignant pleural effusions: pathogenetic and therapeutic implications","volume":"1","author":"Economidou","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.mcp.2022.101793_bib36","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/cas.14584","article-title":"Effect of malignant\u2010associated pleural effusion on endothelial viability, motility and angiogenesis in lung cancer","volume":"111","author":"Changchien","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mcp.2022.101793_bib37","first-page":"304","article-title":"Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor\u2013mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment, Asia Pac","volume":"13","author":"Wang","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib38","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1038\/ncomms15205","article-title":"Mutant KRAS promotes malignant pleural effusion formation","volume":"8","author":"\u0391galioti","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcp.2022.101793_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/LBR.0000000000000789","article-title":"Cytologic investigations for the diagnosis of malignant pleural effusion in non-small cell lung cancer: state-of-the-art review for pulmonologists","volume":"28","author":"Shojaee","year":"2021","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"10.1016\/j.mcp.2022.101793_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/pp-2016-0001","article-title":"Pre-analytical issues in effusion cytology","volume":"1","author":"Michael","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.mcp.2022.101793_bib41","doi-asserted-by":"crossref","first-page":"613071","DOI":"10.3389\/pore.2021.613071","article-title":"Cell-free DNA from pleural effusion samples: is it right for molecular testing in lung adenocarcinoma?","volume":"27","author":"Mok\u00e1nszki","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.mcp.2022.101793_bib42","first-page":"3966","article-title":"Increased plasma DNA integrity in cancer patients","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcp.2022.101793_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbamcr.2015.10.022","article-title":"Characterization of the cell-free DNA released by cultured cancer cells, Biochim","volume":"1863","author":"Bronkhorst","year":"2016","journal-title":"Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.mcp.2022.101793_bib44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1186\/s12885-018-5138-3","article-title":"Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mcp.2022.101793_bib45","first-page":"8813","article-title":"Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing","volume":"7","author":"Lin","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mcp.2022.101793_bib46","article-title":"Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcp.2022.101793_bib47","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027001","article-title":"Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples","volume":"15","author":"Guan","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.mcp.2022.101793_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/PAI.0000000000000543","article-title":"Comparison of epidermal growth factor receptor gene mutations identified using pleural effusion and primary tumor tissue samples in non\u2013small cell lung cancer","volume":"26","author":"Liu","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.mcp.2022.101793_bib49","first-page":"1962","article-title":"Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients","volume":"55","author":"Shin","year":"2017","journal-title":"Clin. Chem. Lab. Med. CCLM."},{"key":"10.1016\/j.mcp.2022.101793_bib50","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/PO.20.00121","article-title":"Turnaround time of plasma next-generation sequencing in thoracic oncology patients: a quality improvement analysis","author":"Lee","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib51","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.bjc.6603428","article-title":"EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib","volume":"95","author":"Kimura","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcp.2022.101793_bib52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1759-7714.12979","article-title":"Prognostic impact of pleural effusion in EGFR\u2010mutant non\u2010small cell lung cancer patients without brain metastasis","volume":"10","author":"Yoshimura","year":"2019","journal-title":"Thorac. Cancer."},{"key":"10.1016\/j.mcp.2022.101793_bib53","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jtd.2018.04.125","article-title":"Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens","volume":"10","author":"Liu","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.mcp.2022.101793_bib54","article-title":"Pleural effusion as a substitute for tumor tissue in detecting EGFR\/ALK mutations in non-small cell lung cancer","volume":"98","author":"Pang","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.mcp.2022.101793_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.21037\/atm-20-7702","article-title":"Standardization of pleural effusion-based tumor mutation burden (TMB) estimation using capture-based targeted sequencing","volume":"9","author":"Yu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mcp.2022.101793_bib56","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American society of clinical oncology and college of American pathologists joint review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mcp.2022.101793_bib57","series-title":"Cell-Free DNA Diagn. Markers Methods Protoc.","first-page":"13","article-title":"Cell-free DNA: an overview of sample types and isolation procedures","author":"Martignano","year":"2019"},{"key":"10.1016\/j.mcp.2022.101793_bib58","article-title":"ctDNA analysis for cancer? Not so fast","volume":"8","author":"A.A. for C. Research","year":"2018","journal-title":"Cancer Discov."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:17:29Z","timestamp":1760192249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850822000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":58,"alternative-id":["S0890850822000044"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101793","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101793"}}